Volume 130, Issue 4, Pages (April 2006)

Slides:



Advertisements
Similar presentations
Volume 130, Issue 4, Pages (April 2006)
Advertisements

Volume 10, Pages (August 2016) A Single Human Papillomavirus Vaccine Dose Improves B Cell Memory in Previously Infected Subjects  Erin M. Scherer,
Identification of EpCAM as the Gene for Congenital Tufting Enteropathy
Volume 6, Issue 4, Pages (October 2000)
Volume 117, Issue 1, Pages (July 1999)
Volume 152, Issue 5, Pages (April 2017)
Volume 133, Issue 3, Pages (September 2007)
Volume 150, Issue 4, Pages (April 2016)
Volume 137, Issue 5, Pages (November 2009)
Prediction of virological response by pretreatment hepatitis B virus reverse transcriptase quasispecies heterogeneity: the advantage of using next-generation.
Volume 134, Issue 3, Pages e2 (March 2008)
Volume 133, Issue 1, Pages (July 2007)
Volume 142, Issue 5, Pages e3 (May 2012)
Level of Hepatitis B Virus DNA in Inactive Carriers With Persistently Normal Levels of Alanine Aminotransferase  Chia–Ming Chu, Yi–Cheng Chen, Dar–In.
Epigenetic Inhibition of Nuclear Receptor Small Heterodimer Partner Is Associated With and Regulates Hepatocellular Carcinoma Growth  Nan He, Kyungtae.
Hepatitis B and C virus-related carcinogenesis
Volume 127, Issue 6, Pages (December 2004)
IgA and IgM VH repertoires in human colon: Evidence for clonally expanded B cells that are widely disseminated  Wolfgang Holtmeier, Andreas Hennemann,
In Vitro Recapitulating of TP53 Mutagenesis in Hepatocellular Carcinoma Associated With Dietary Aflatoxin B1 Exposure  Ahmad Besaratinia, Sang-in Kim,
Volume 129, Issue 1, Pages (July 2005)
Volume 133, Issue 3, Pages (September 2007)
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
Volume 136, Issue 2, Pages (February 2009)
Volume 113, Issue 3, Pages (August 2017)
Volume 61, Issue 2, Pages (August 2014)
Volume 154, Issue 4, Pages (March 2018)
Efficacy of Serologic Marker Screening in Identifying Hepatitis B Virus Infection in Organ, Tissue, and Cell Donors  Dominique Challine, Stéphane Chevaliez,
Volume 133, Issue 5, Pages (November 2007)
Volume 135, Issue 1, Pages (July 2008)
Volume 130, Issue 4, Pages (April 2006)
Volume 132, Issue 4, Pages (April 2007)
Volume 146, Issue 1, Pages e35 (January 2014)
Volume 136, Issue 2, Pages e3 (February 2009)
Volume 127, Issue 5, Pages (November 2004)
Biotechnology Challenges to In Vitro Maturation of Hepatic Stem Cells
Comprehensive analysis of mutations in the hepatitis delta virus genome based on full- length sequencing in a nationwide cohort study and evolutionary.
Volume 136, Issue 7, Pages (June 2009)
Navigating the Maze of Hepatitis B Treatments
Volume 150, Issue 4, Pages (April 2016)
Volume 117, Issue 3, Pages (September 1999)
Volume 142, Issue 6, Pages e3 (May 2012)
Whole genome characterization of hepatitis B virus quasispecies with massively parallel pyrosequencing  F. Li, D. Zhang, Y. Li, D. Jiang, S. Luo, N. Du,
Mapping Global Histone Acetylation Patterns to Gene Expression
Cost Effectiveness of Universal Screening for Hepatitis C Virus Infection in the Era of Direct-Acting, Pangenotypic Treatment Regimens  Mark H. Eckman,
A Novel MAP Kinase Regulates Flagellar Length in Chlamydomonas
Genotype/Phenotype Analysis of a Photoreceptor-Specific ATP-Binding Cassette Transporter Gene, ABCR, in Stargardt Disease  Richard Alan Lewis, Noah F.
Volume 132, Issue 7, Pages (June 2007)
lin-35 and lin-53, Two Genes that Antagonize a C
A Multi-Exonic BRCA1 Deletion Identified in Multiple Families through Single Nucleotide Polymorphism Haplotype Pair Analysis and Gene Amplification with.
Hepatitis B and C virus-related carcinogenesis
Volume 137, Issue 5, Pages (November 2009)
Qiong A. Liu, Michael O. Hengartner  Current Biology 
Gang Wang, Na Zhao, Ben Berkhout, Atze T Das  Molecular Therapy 
Volume 132, Issue 1, Pages 5-6 (January 2007)
Prevalence and Treatment of Hepatitis C Virus Genotypes 4, 5, and 6
A Mutation in the Variable Repeat Region of the Aggrecan Gene (AGC1) Causes a Form of Spondyloepiphyseal Dysplasia Associated with Severe, Premature.
Noninvasive Diagnosis of Hepatic Fibrosis in Patients With Chronic Hepatitis C by Splenic Doppler Impedance Index  Chen–Hua Liu, Shih–Jer Hsu, Jou–Wei.
Volume 128, Issue 3, Pages (March 2005)
Deletion of PREPL, a Gene Encoding a Putative Serine Oligopeptidase, in Patients with Hypotonia-Cystinuria Syndrome  Jaak Jaeken, Kevin Martens, Inge.
Targeted Genome Editing in Genes and cis-Regulatory Regions Improves Qualitative and Quantitative Traits in Crops  Xitao Li, Yongyao Xie, Qinlong Zhu,
Volume 12, Issue 1, Pages (July 2015)
Volume 126, Issue 4, Pages (April 2004)
Jia-Horng Kao*, Pei-Jer Chen*, Ming-Yang Lai*, Ding-Shinn Chen‡,§ 
Raymond D’Souza, Michael J
Comprehensive analysis of mutations in the hepatitis delta virus genome based on full- length sequencing in a nationwide cohort study and evolutionary.
Mark S. Dunstan, Debraj GuhaThakurta, David. E. Draper, Graeme L. Conn 
Volume 125, Issue 4, Pages (October 2003)
Hepatitis B genotypes correlate with tumor recurrence after curative resection of hepatocellular carcinoma  Jin-de Chen, Chun-jen Liu, Po-huang Lee, Pei-jer.
Volume 14, Issue 15, Pages (August 2004)
Volume 156, Issue 4, Pages (March 2019)
Presentation transcript:

Volume 130, Issue 4, Pages 1153-1168 (April 2006) High Prevalence and Mapping of Pre-S Deletion in Hepatitis B Virus Carriers With Progressive Liver Diseases  Bing–Fang Chen, Chun–Jen Liu, Guey–Mei Jow, Pei–Jer Chen, Jia–Horng Kao, Ding–Shinn Chen  Gastroenterology  Volume 130, Issue 4, Pages 1153-1168 (April 2006) DOI: 10.1053/j.gastro.2006.01.011 Copyright © 2006 American Gastroenterological Association Institute Terms and Conditions

Figure 1 Immune epitopes and functional domains within the HBV pre-S region. The pre-S region consists of the pre-S1 and pre-S2 domains. The pre-S1 domain contains 119 amino acids (used in this study) and is further divided into 2 parts: N half (aa 1–57) and C half (aa 58–119). The pre-S2 domain contains 55 amino acids. The pre-S domain contains many B or T epitopes and exerts multiple functions as shown. N half of pre-S1 contains a hepatocyte-binding site essential for infection. C half of pre-S1 contains a heat shock protein 70 (Hsc70)-binding site and cytosolic anchorage determinant (CAD) important for dual topology of L proteins and a nucleocapsid-binding site for virion morphogenesis. C half of pre-S1 also contains an S-promoter and a CCAAT binding factor (CBF)-binding site necessary for expression of S gene. Pre-S2 domain has a polymerized human serum albumin (pHSA)-binding site. Solid triangle, myristylation at second amino acid; open triangle, N-link glycosylation at N-4 of the M protein; shaded triangle, O-link glycosylation at T-37 of the M protein. Gastroenterology 2006 130, 1153-1168DOI: (10.1053/j.gastro.2006.01.011) Copyright © 2006 American Gastroenterological Association Institute Terms and Conditions

Figure 2 Prevalence of pre-S deletion mutants in 152 patients infected with genotype B, C, or mixed genotypes (genotype B, C, and/or recombinants). The frequency of pre-S deletion increased with advancing clinical stages in both genotypes B- and C-infected patients (2.5% and 25% in chronic carriers to 50.0% and 57.1% in hepatocellular carcinoma patients for genotypes B and C, respectively). Genotype C has a higher frequency of pre-S deletion than genotype B. The number shown in each bar represents the number of cases in each category. CC, chronic carrier; CH, chronic hepatitis; LC, cirrhosis; HCC, hepatocellular carcinoma. Gastroenterology 2006 130, 1153-1168DOI: (10.1053/j.gastro.2006.01.011) Copyright © 2006 American Gastroenterological Association Institute Terms and Conditions

Figure 3 The amino acid sequences of the 88 pre-S1/S2 deletion mutants from 3 chronic carriers, 9 chronic hepatitis, 7 cirrhosis (3A), and 25 hepatocellular carcinoma patients (3B). Mapping of the wild-type pre-S1/S2 domain is shown at the top, and the number above the map indicates the amino acid site of the defined domain. Shaded box indicates the deleted region; dot box indicates frame shift mutation, and the number in the box indicates the length of this box. *Nonsense mutation, and ▵ indicates point mutation of the start codon. Deletions were more often in the C half of pre-S1 (45 of 88, 51.1%) and the N terminus of pre-S2 domain (60 of 88, 68.2%). The deletion of 5 functional sites are indicated and shown at right hand column. S, T, N, M, and P indicate 5 functional sites: S-promoter, topology (CAD or Hsc70 binding site), nucleocapsid binding site, the start codon of M protein, and pHSA site, respectively. +, −, and ▵ indicate presence of deletion, absence of deletion, and point mutation, respectively. Gastroenterology 2006 130, 1153-1168DOI: (10.1053/j.gastro.2006.01.011) Copyright © 2006 American Gastroenterological Association Institute Terms and Conditions

Figure 3 The amino acid sequences of the 88 pre-S1/S2 deletion mutants from 3 chronic carriers, 9 chronic hepatitis, 7 cirrhosis (3A), and 25 hepatocellular carcinoma patients (3B). Mapping of the wild-type pre-S1/S2 domain is shown at the top, and the number above the map indicates the amino acid site of the defined domain. Shaded box indicates the deleted region; dot box indicates frame shift mutation, and the number in the box indicates the length of this box. *Nonsense mutation, and ▵ indicates point mutation of the start codon. Deletions were more often in the C half of pre-S1 (45 of 88, 51.1%) and the N terminus of pre-S2 domain (60 of 88, 68.2%). The deletion of 5 functional sites are indicated and shown at right hand column. S, T, N, M, and P indicate 5 functional sites: S-promoter, topology (CAD or Hsc70 binding site), nucleocapsid binding site, the start codon of M protein, and pHSA site, respectively. +, −, and ▵ indicate presence of deletion, absence of deletion, and point mutation, respectively. Gastroenterology 2006 130, 1153-1168DOI: (10.1053/j.gastro.2006.01.011) Copyright © 2006 American Gastroenterological Association Institute Terms and Conditions

Figure 4 The nucleotide sequences of the pre-S clones obtained from 3 patients. RB2-4, RB2-1, and RB2-5 isolated from chronic carrier RB2; D6-2, D6-5, and D6-8 from HCC patient D6; G2-3, G2-9, G2-1, and G2-8 from HCC patient G2. Reference sequences of genotype B isolate (AY293309) and genotype C isolate (AF233236) are shown at the top. Positions of nucleotide sequences of the pre-S region and the start codon of pre-S1 and pre-S2 genes are indicated above the reference sequence. The dashes indicate identical sequences compared with the reference sequences of genotype B isolate. The slashes indicate deletion. RB2-4, D6-2, and G2-3 are genotype B; D6-5 and G2-9 are genotype C; RB2-1, RB2-5, D6-8, G2-1, and G2-8 are recombinants between HBV genomes of genotypes B and C. Gastroenterology 2006 130, 1153-1168DOI: (10.1053/j.gastro.2006.01.011) Copyright © 2006 American Gastroenterological Association Institute Terms and Conditions

Figure 5 Plots of similarity (generated by SimPlot) of a set of reference sequences to those of (A) RB2-1, (B) RB2-5, (C) D6-8, (D) G2-1, and (E) G2-8 clones. The reference sequences involved in recombination are genotype B (AY293309, black line) and genotype C (AF233236, gray line) and an out group sequence genotype F (AB036910, dotted line). Each curve is a comparison between the query sequence (pre-S region) and a reference sequence. Each point plotted is the percentage identity within a sliding window 100 base pairs wide centered on the position plotted, with a step size between points of 20 base pairs, and GapStrip off. The horizontal bars above plots are a cartoon of the pre-S regions of these recombinants. The colors are consistent with those used for the similarity curves and indicate the genotype to which that part of genome is most similar based on the adjacent similarity plot. Gastroenterology 2006 130, 1153-1168DOI: (10.1053/j.gastro.2006.01.011) Copyright © 2006 American Gastroenterological Association Institute Terms and Conditions

Figure 6 The proposed model for the generation of deletion mutants and their possible roles in liver damage and carcinogenesis. Gastroenterology 2006 130, 1153-1168DOI: (10.1053/j.gastro.2006.01.011) Copyright © 2006 American Gastroenterological Association Institute Terms and Conditions